Biotech News

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance

Si-Bone (SIBN)Si-Bone2026-06-25 13:46 ESTEarnings

Delivered ~ 21% worldwide revenue growth, ~ 5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $48.7 million , representing growth of 20.6% U.S.

Open original release

Related news

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026

View all latest news

Si-Bone

Si-Bone is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

SIBNSi-Bone2026-06-26 12:07 EST

SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026

SIBNSi-Bone2026-06-26 12:07 EST

SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance

SIBNSi-Bone2026-06-26 12:07 EST

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

SIBNSi-Bone2026-06-26 12:07 EST

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

SIBNSi-Bone2026-06-26 12:07 EST

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States